For how we live.
Implanted electrodes now decode attempted speech into text for people who cannot speak. Results are striking — up to 62 words a minute — but come from single participants, need brain surgery, and remain research.
A 614-donor autopsy study tied advanced CTE to dementia independently of other brain disease. A separate imaging report in three former athletes hints at a test for the living. The caveats on both are heavy.
A once-daily experimental pill beat placebo in a phase 3 trial and is under regulatory review — yet no study has tested its claimed edge over older dopamine agonists head-to-head.
The CHMP backed tolebrutinib for non-relapsing secondary progressive multiple sclerosis, a population with no prior disability-targeting treatment. The trial showed a 31% delay in progression.
In 99 patients with normal-pressure hydrocephalus, an open shunt valve improved gait velocity and balance versus a valve set so high it did nothing. Cognition and bladder control did not improve.